Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Nanoparticles made from hafnium dioxide (hafnia; HfO2) have emerged as a potential enhancer of cancer radiation therapy. Such nanoparticles allow for reduced doses of radiation to be used on tumors, sparing healthy tissue from side effects without reducing its anti-cancer effects. However, despite their potential, it is not yet known how different nanoparticle properties, such as size and shape, effect their efficacy or risk of side effects. This project thus aims to gain an understanding of the relationship between nanoparticle properties and their biological effects. Several different types of HfO2 nanoparticles will be created, examined, and carefully compared regarding their toxicity and performance under medical X-Rays. Such information will be crucial to the development, regulation, and clinical trials/applications of future nanomedicines.
Mark Servos;Xu Zhang
Grand River Hospital
Physics
Health and Related Sciences & Technology; Professional, scientific and technical services
University of Waterloo
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.